LCS3

Overview

LCS3 is a reversible and uncompetitive glutathione disulfide reductase ( GSR ) and thioredoxin reductase 1 ( TXNRD1 ) inhibitor ( IC 50 =3.3 µM and 3.8 µM, respectively). LCS3 shows anti-tumor activity, and induces apoptosis . LCS3 can be used in lung adenocarcinoma (LUAD) research.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Digestive System Inflammation | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-147328
• CAS No.: 109844-92-0
• Molecular Formula: C11H7ClN2O4
• Molecular Weight: 266.64
• Purity: 99.43%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: ≥ 2.5 mg/mL (9.38 mM); Clear solution
• Availability: In-stock

Source

Original product source